Galantamine-Memantine Combination in the Treatment of Parkinson’s Disease Dementia
Emma D. Frost(Cooper University Health Care), Maju Mathew Koola(George Washington University), Briana P. Murray(Chase Brexton Health Care), Balaji Krishnaiah(University of Tennessee Health Science Center), Thomas N. Ferraro(Cooper Medical School of Rowan University), Ian M. Walker(Cooper Medical School of Rowan University), Khalid A. Hanafy(Beth Israel Deaconess Medical Center), Jamir Pitton Rissardo(Cooper University Hospital), Nicholas Vigilante(Cooper Medical School of Rowan University), Ludmil Mitrev(Cooper Medical School of Rowan University), David B. Lovejoy(Macquarie University), Shafiqur Rahman(South Dakota State University), Andrew McGarry(Cooper Medical School of Rowan University), Vishnu Byroju(Cooper University Health Care), Mitchel A. Kling, Jack Donlon(Cooper Medical School of Rowan University), Trevor W. Stone(Nuffield Orthopaedic Centre), Valentina Echeverrı́a(San Sebastián University)
Cited by 11
Related Papers
Major Depression Is Associated with Significant Diurnal Elevations in Plasma Interleukin-6 Levels, a Shift of Its Circadian Rhythm, and Loss of Physiological Complexity in Its Secretion: Clinical Implications
|The Journal of Clinical Endocrinology & Metabolism|2005|376
An expanding range of targets for kynurenine metabolites of tryptophan
|Trends in Pharmacological Sciences|2012|335
Microglia regulate blood clearance in subarachnoid hemorrhage by heme oxygenase-1
|Journal of Clinical Investigation|2015|219